These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34445314)

  • 41. Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice.
    Oana K; Oma Y; Suo S; Takahashi MP; Nishino I; Takeda S; Ishiura S
    Sci Rep; 2013; 3():2142. PubMed ID: 23828222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
    Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
    FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
    Ozimski LL; Sabater-Arcis M; Bargiela A; Artero R
    Biol Rev Camb Philos Soc; 2021 Apr; 96(2):716-730. PubMed ID: 33269537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1.
    Picchio L; Legagneux V; Deschamps S; Renaud Y; Chauveau S; Paillard L; Jagla K
    Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development.
    Hale MA; Bates K; Provenzano M; Johnson NE
    Hum Mol Genet; 2023 Apr; 32(9):1413-1428. PubMed ID: 36222125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1.
    Klinck R; Fourrier A; Thibault P; Toutant J; Durand M; Lapointe E; Caillet-Boudin ML; Sergeant N; Gourdon G; Meola G; Furling D; Puymirat J; Chabot B
    PLoS One; 2014; 9(9):e107324. PubMed ID: 25211016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptome alterations in myotonic dystrophy skeletal muscle and heart.
    Wang ET; Treacy D; Eichinger K; Struck A; Estabrook J; Olafson H; Wang TT; Bhatt K; Westbrook T; Sedehizadeh S; Ward A; Day J; Brook D; Berglund JA; Cooper T; Housman D; Thornton C; Burge C
    Hum Mol Genet; 2019 Apr; 28(8):1312-1321. PubMed ID: 30561649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
    Gladman JT; Mandal M; Srinivasan V; Mahadevan MS
    PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2.
    Cappella M; Perfetti A; Cardinali B; Garcia-Manteiga JM; Carrara M; Provenzano C; Fuschi P; Cardani R; Renna LV; Meola G; Falcone G; Martelli F
    Cell Death Dis; 2018 Jun; 9(7):729. PubMed ID: 29955039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
    Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
    Koebis M; Ohsawa N; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Genes Cells; 2011 Sep; 16(9):961-72. PubMed ID: 21794030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.
    Furling D; Lemieux D; Taneja K; Puymirat J
    Neuromuscul Disord; 2001 Nov; 11(8):728-35. PubMed ID: 11595515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.
    Botta A; Vallo L; Rinaldi F; Bonifazi E; Amati F; Biancolella M; Gambardella S; Mancinelli E; Angelini C; Meola G; Novelli G
    Gene Expr; 2007; 13(6):339-51. PubMed ID: 17708420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy.
    Thomas JD; Sznajder ŁJ; Bardhi O; Aslam FN; Anastasiadis ZP; Scotti MM; Nishino I; Nakamori M; Wang ET; Swanson MS
    Genes Dev; 2017 Jun; 31(11):1122-1133. PubMed ID: 28698297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model.
    Llamusi B; Bargiela A; Fernandez-Costa JM; Garcia-Lopez A; Klima R; Feiguin F; Artero R
    Dis Model Mech; 2013 Jan; 6(1):184-96. PubMed ID: 23118342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing.
    Paul S; Dansithong W; Kim D; Rossi J; Webster NJ; Comai L; Reddy S
    EMBO J; 2006 Sep; 25(18):4271-83. PubMed ID: 16946708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.
    Neault N; Ravel-Chapuis A; Baird SD; Lunde JA; Poirier M; Staykov E; Plaza-Diaz J; Medina G; Abadía-Molina F; Jasmin BJ; MacKenzie AE
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.
    Herrendorff R; Faleschini MT; Stiefvater A; Erne B; Wiktorowicz T; Kern F; Hamburger M; Potterat O; Kinter J; Sinnreich M
    J Biol Chem; 2016 Aug; 291(33):17165-77. PubMed ID: 27298317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.